You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 2, February 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Supranormal 25-Hydroxyvitamin D and Subnormal 1,25-Dihydroxyvitamin D

Their Role in X-linked Hypophosphatemic Rickets

Russell W. Chesney, MD; Richard B. Mazess, PhD; Philip Rose; Alan J. Hamstra, MS; Hector F. DeLuca, PhD

Am J Dis Child. 1980;134(2):140-143.


Abstract

• Serum 25-hydroxyvitamin D (25-OH-D) and 1,25-dihydroxyvitamin D (1,25-(OH)2D) and bone mineral content by the photon-absorption technique were determined in eight patients with X-linked hypophosphatemic rickets treated for at least 24 months with oral sodium phosphate and high-dosage ergocalciferol (vitamin D2). Mean 25-OH-D2 level was 129.5 ± 67.5 ng/mL (mean ± SD); the level of 25-OH-D3 was 10.5 ± 5.8 ng/mL. These values were significantly higher than in normal subjects (total 25-OH-D mean of 27 ± 10 ng/mL). Serum 1,25-(OH)2D was 16.9 ± 8.5 pg/ml (mean ± SD) in the eight patients, significantly lower than 47 ± 16 pg/mL in 27 age-matched controls. Values indicative of significant demineralization were found in seven of the eight phosphate-treated patients, who had no radiologic evidence of rickets. These results suggest that any theory of the pathogenesis of this disorder must account for inappropriate renal vitamin D metabolism and for renal hyperphosphaturia. The failure of high-dosage oral phosphate and ergocalciferol to fully correct demineralization may suggest a role for calcitriol (1,25-(OH)2D3) as a therapeutic agent.

(Am J Dis Child 134:140-143, 1980)



Author Affiliations

From the Departments of Pediatrics (Dr Chesney), Radiology (Mr Rose and Dr Mazess), and Biochemistry (Dr DeLuca and Mr Hamstra), the University of Wisconsin Center for Health Sciences, Madison, Wis; the College of Agricultural and Life Sciences (Dr DeLuca and Mr Hamstra), Madison, Wis.


Footnotes

Reprint requests to the Department of Pediatrics, Clinical Sciences Center, University of Wisconsin, 600 Highland Ave, Madison, WI 53792 (Dr Chesney).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence for Abnormal Translational Regulation of Renal 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Activity in the Hyp-Mouse
Yuan et al.
Endocrinology 2004;145:3804-3812.
ABSTRACT | FULL TEXT  

Vitamin D Metabolism in Hypophosphatemic Rickets
Mason et al.
Arch Pediatr Adolesc Med 1982;136:909-913.
ABSTRACT  

Rickets of Prematurity: Supranormal Levels of Serum 1,25-Dihydroxyvitamin D
Chesney et al.
Arch Pediatr Adolesc Med 1981;135:34-37.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.